The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Kane Biotech Inc closed at $0.12.

Over the last five days, shares have lost 14.29% and are down 4.00% for the last year to date. This security has underperformed the S&P TSX by 31.88% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.08
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,041.33%

Although this company's net profit margin is negative, it is above the industry average and implies that Kane Biotech Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense1111
Selling / general / administrative0011
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income0-1-1-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-1-1-1
Income after tax-1-1-1-1
Income tax, total--------
Net income-1-1-1-1
Total adjustments to net income--------
Net income before extra. items-1-1-1-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-1-1
Inc. avail. to common incl. extra. items-1-1-1-1
Diluted net income-1-1-1-1
Dilution adjustment--------
Diluted weighted average shares46353024
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.02-0.03-0.02
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.01-0.02-0.03-0.02